Adaptive plots splitting Pfizer-partnered drug discovery unit from diagnostics business

Adaptive Biotechnologies is planning to separate its drug discovery and diagnostics businesses, outlining its intent to evaluate “strategic and structural alternatives” for the medicine wing of the company